In Ex parte Michalek, Attraction No. 2023-004204 (PTAB Dec. 27, 2024), the Patent Trial and Attraction Board (PTAB) evaluated an invention involving medical well being know-how and synthetic intelligence. The PTAB particularly acknowledged that the patent claims at subject recited new details about the nexus between sure biomarkers and improvement of lung most cancers as facilitated by machine studying. In truth, previous to enchantment, the applicant had efficiently overcome all rejections below part 103. However, primarily based on Patent Workplace steering, the PTAB nonetheless decided the claims had been flawed from the attitude of material eligibility. Though the details on this resolution concern medical well being innovation, the choice is useful to tell patent technique for AI enabled innovations throughout varied disciplines and industries.
Trending
- Aputure NOVA II 2×1 Launched – Kicking Off a New Generation of Panels
- Snoring, late-night TV, and melatonin gummies: Sleep doctor warns your ‘harmless’ habits may actually be wrecking rest and brain health | Health News
- Jimmy Kimmel returns to the airwaves by local TV groups
- Kenko Tokina ends production of the Zeiss Loxia lenses
- I Taught Middle School; Here’s How I Built Trust With Parents
- China launches campaign to keep killjoys off the internet
- One of a Kind Ultra-Wide Angle Zoom: We Review the Schneider Kreuznach X LK Samyang 14-24mm f/2.8 Lens
- AI Startup Friend Bets On Foes With $1M NYC Subway Campaign
Leveraging Patent Office Examples for AI Enabled Innovation In Any Industry
